Hemostasis Today

October, 2026
October 2026
M T W T F S S
 1234
567891011
12131415161718
19202122232425
262728293031  
Priya Sriskandarajah: HEMA-MED Trial Exploring Roginolisib Plus JAK Inhibitors in Myelofibrosis
Oct 1, 2026, 23:44

Priya Sriskandarajah: HEMA-MED Trial Exploring Roginolisib Plus JAK Inhibitors in Myelofibrosis

Priya Sriskandarajah, Consultant Haematologist at Guy’s and St Thomas’​ NHS Foundation Trust, shared a post on LinkedIn about a recent article she and her colleagues co-authored, published in OncoTargets and Therapy, adding:

“Do check out our paper just published in OncoTargets and Therapy which covers the ongoing Hema-MED trial combining JAK inhibitors with the PI3K inhibitor Rogilinosib in MF patients.

Delighted to be running this study at Guy’s and St Thomas’​ NHS Foundation Trust.”

Title: Managing thrombotic risk in myeloproliferative disorders

Authors: Jasson Villarreal Hernandez, Javier Octavio Díaz Carbonero, Chiara Paoli, Paola Guglielmelli, Mario Tiribelli, Francesca Palandri, Jesus Maria Hernandez-Rivas, María Laura Fox, Damián Cubillas García de la Torre, Graeme Greenfield, Ciro Rinaldi, Priya Sriskandarajah, Claire Harrison, Fabrizio Pane, Giuseppe Lanzarone, Daniela Cilloni, Matteo Pacilli, Massimo Breccia, Michael Lahn, Giusy Di Conza, Tracey C Hammett, Paramjit Kaur, Michael Emig, Karen M Tonge, Mireille Cantarini, Johanne Polasek, Alessandro Lucchesi, Armando Santoro, Alessandro Maria Vannucchi

Priya Sriskandarajah

Stay updated on all scientific advances with Hemostasis Today.